130 results
Page 6 of 7
6-K
EX-99.2
wpmydmaixocw8ejf4
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
ul8iga2n cvw
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
itgaw v0l42
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.3
ygp15ty41 xi8inptug4
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
gnxp8
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
c5nzwhbh 5d3
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
ilivetoyvznjkmnuw
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
t46qy
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
6-K
EX-99.1
bbsmiw7 ksrksamzt
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
4hpltclvhxwg1
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
8rzk5jegw zq2xnu7
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
9fjxj
8 Jan 21
Registration statement (foreign)
4:58pm
F-1
EX-5.1
x0gub69wmw2cy
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
dxj4k0zf7pkg07vdo2x
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
9kuydl
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
729rftdov
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
j2usfub9f5x 3lp0kgpq
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
ke2yltdqb59tw
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
prrm 2ypery
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
ycognja13r
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am